Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure.

Arzneimittelforschung. 1997 Jul;47(7):889-92. Unique Identifier : AIDSLINE MED/97418245
Marastoni M; Bergonzoni M; Bortolotti F; Tomatis R; Department of Pharmaceutical Science, University of Ferrara, Italy.

Abstract: Two series of symmetry-based HIV protease inhibitors containing S,S) or (R,R) tartaric acid core structure were prepared and tested for inhibitory property against the enzyme. All compounds showed weak antiprotease activity.
Keywords: *HIV Protease Inhibitors/CHEMISTRY *Tartrates/CHEMISTRYKWDhivproteaseinhibitors/chemistryKWDtartrates/chemistry
971230
M97C0654

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .